Lam Thomas S.

SEC source: 0001104659-26-114777 · tm2627257-1_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 463,033

F2 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 6, 2026.

F3 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 13,334 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 36,459 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 6, 2027 (subject to continuous employment with the Issuer and/or its affiliates).

SEC source: 0001104659-26-040955 · tm2611344-3_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 465,657

F2 · shares: Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer and/or its affiliates on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 6, 2026.

F3 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer and/or its affiliates): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 13,334 shares, which will vest in two equal annual installments beginning on April 1, 2027. Also includes 41,667 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026 (subject to continuous employment with the Issuer and/or its affiliates).

SEC source: 0001104659-26-025236 · tm268271-3_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 423,990

F2 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with shares of restricted stock that vested on March 5, 2026.

F3 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 51,667 shares, which will vest in two equal annual installments beginning on March 5, 2027; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.

SEC source: 0001104659-25-119985 · tm2533040-1_4seq1.xml · derivative · entry 5

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,502 shares

Expires 2025-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-25-119985 · tm2533040-1_4seq1.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 433,256

F3 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 77,500 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.

SEC source: 0001104659-25-119985 · tm2533040-1_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 459,122

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-25-021864 · tm258649-2_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 429,620

F2 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.

F3 · balance_after: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 77,500 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.

SEC source: 0001104659-25-014912 · tm253769-1_4seq1.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,133,706

F3 · kind: Represents the receipt of shares of the Issuer's common stock pursuant to the pro rata distribution for no consideration by APC, of which the Reporting Person is a stockholder.

SEC source: 0001104659-25-014912 · tm253769-1_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Allied Physicians of California, a Professional Medical Corporation

Disclosed balance after: 6,132,802

F2 · kind: APC distributed these shares of the Issuer's common stock to its stockholders, pursuant to a pro rata distribution for no consideration. Includes 17,839 shares in the aggregate held for the benefit of disqualified shareholders of APC.

F2 · shares: APC distributed these shares of the Issuer's common stock to its stockholders, pursuant to a pro rata distribution for no consideration. Includes 17,839 shares in the aggregate held for the benefit of disqualified shareholders of APC.

F1 · ownership.nature: These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation ("APC"), of which the Reporting Person is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-25-005342 · tm253769-4_4seq1.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,832,698

F2 · kind: On January 17, 2025, the issuer entered into a stock repurchase agreement with APC, pursuant to which the issuer agreed to repurchase 300,000 shares of the issuer's common stock from APC. The agreement closed, and the issuer completed the stock repurchase, on the same day. The issuer's Board of Directors and the Audit Committee of the Board of Directors approved the repurchase.

F1 · ownership.direct: Allied Physicians of California, a Professional Medical Corporation ("APC"), is a consolidated affiliate of the issuer of which Dr. Kenneth Sim, the issuer's Executive Chairman of the Board of Directors, is Chairman and a director and stockholder, and Dr. Thomas Lam, the issuer's Vice Chairman of the Board of Directors, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. Each of Dr. Sim and Dr. Lam disclaims beneficial ownership of the securities held by APC except to the extent of his pecuniary interest therein. Each of Dr. Sim and Dr. Lam holds, directly and/or indirectly, additional securities of the issuer.

SEC source: 0001104659-24-116856 · tm2428142-5_4seq1.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,855

F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall, based on the date the performance goal is achieved, vest either (i) in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors or (ii) three annual installments of 50%, 25% and 25%, respectively, beginning on a date during the first quarter of 2026 to be determined by the compensation committee.

F4 · balance_after: Includes 130,000 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 43,333 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; and (ii) grants of 30,000 shares, 30,000 shares and 26,667 shares, each of which will vest upon achievement of certain pre-established performance goals.

SEC source: 0001104659-24-116856 · tm2428142-5_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 412,188

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.

SEC source: 0001104659-24-098982 · tm2423811-3_4seq1.xml · derivative · entry 5

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,046 shares

Expires 2024-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-24-098982 · tm2423811-3_4seq1.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398,855

F3 · balance_after: Includes 111,748 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,748 shares, which will vest on November 2, 2024; (ii) 30,000 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; (iii) 30,000 shares, which will vest upon achievement of certain pre-established performance goals; and (iv) 30,000 shares, which will vest upon achievement of certain pre-established performance goals.

SEC source: 0001104659-24-098982 · tm2423811-3_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,901

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-23-126900 · tm2333076-5_4seq1.xml · nonDerivative · entry 3

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,855

F4 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall, based on the date the performance goal is achieved, vest either (i) in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors or (ii) three annual installments of 15,000, 7,500 and 7,500, respectively, beginning on a date during the first quarter of 2026 to be determined by the compensation committee.

F5 · balance_after: Includes 111,748 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,748 shares, which will vest on November 2, 2024; (ii) 30,000 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; (iii) 30,000 shares, which will vest upon achievement of certain pre-established performance goals; and (iv) 30,000 shares, which will vest upon achievement of certain pre-established performance goals.

SEC source: 0001104659-23-126900 · tm2333076-5_4seq1.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,855

F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall vest in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.

SEC source: 0001104659-23-126900 · tm2333076-5_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,855

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.

SEC source: 0001104659-23-119144 · tm2330683-1_4seq1.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · Co-CEO and President

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,132,698

F2 · kind: On November 6, 2023, the issuer entered into a stock repurchase agreement with APC, pursuant to which the issuer agreed to repurchase approximately $100 million of the issuer's common stock from APC. Pursuant to such agreement, on November 14, 2023, the issuer repurchased 3,166,561 shares of common stock from APC. The issuer's Board of Directors and the Audit Committee of the Board of Directors approved the repurchase.

F1 · ownership.direct: Allied Physicians of California, a Professional Medical Corporation ("APC") is a consolidated affiliate of the issuer of which Dr. Thomas Lam, the issuer's Co-Chief Executive Officer and President and a director, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder; Dr. Kenneth Sim, the issuer's Executive Chairman, is Chairman and a director and stockholder; and Dr. Albert Young, the issuer's Chief Administrative Officer, is Senior Executive Vice President and a director and stockholder. Each of Dr. Lam, Dr. Sim and Dr. Young disclaims beneficial ownership of the securities held by APC except to the extent of his pecuniary interest therein. Each of Dr. Lam, Dr. Sim and Dr. Young holds, directly and/or indirectly, additional securities of the issuer.

SEC source: 0001250853-22-000120 · primary_doc.xml · derivative · entry 4

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,262.84 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share.

SEC source: 0001250853-22-000120 · primary_doc.xml · derivative · entry 3

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 55,337.13 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share.

SEC source: 0001250853-22-000120 · primary_doc.xml · nonDerivative · entry 2

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,299,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person.

SEC source: 0001250853-22-000120 · primary_doc.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,246,997

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person.

SEC source: 0001250853-22-000118 · primary_doc.xml · derivative · entry 6

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 48,585.84 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share , (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer).

SEC source: 0001250853-22-000118 · primary_doc.xml · derivative · entry 5

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 51,442.83 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share , (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer).

SEC source: 0001250853-22-000118 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,855

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001250853-22-000118 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,270

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001250853-22-000115 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,107,474

F3 · kind: Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied, of which the Reporting Person is a director, officer and shareholder.

SEC source: 0001250853-22-000115 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Allied Physicians of California, A Professional Medical Corporation

Disclosed balance after: 10,191,660

F1 · kind: Allied Physicians of California, A Profession Medical Corporation ("Allied"), of which the Reporting Person is a director, officer and shareholder, distributed these shares as an in-kind dividend to its shareholders.

F2 · balance_after: These securities are beneficially owned by Allied, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001250853-22-000096 · primary_doc.xml · nonDerivative · entry 3

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wife

Disclosed balance after: 0

F3 · balance_after: On September 17, 2020, the spouse of the Reporting Person contributed 564, 691 shares of AMEH common stock to a grantor retained annuity trust (the JL GRAT) for the benefit of herself and her children. On September 27, 2021 45,836 shares were distributed from the JL GRAT to the Family Trust in satisfaction of an annuity obligation. On September 22, 2022, 135,090 shares were distributed from the JL GRAT to the Family Trust in satisfaction of an annuity obligation. Upon termination of the trust on September 27, 2022, the remaining 383,764 shares were transferred to the children of the Reporting Person. The 180,926 shares previously distributed to the Family Trust will continue to be reported as indirectly owned by the Reporting Person.

SEC source: 0001250853-22-000096 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By grantor retained annuity trust

Disclosed balance after: 0

F2 · balance_after: On September 17, 2020, the Reporting Person contributed 564,691 shares of AMEH common stock to a grantor retained annuity trust (the TL GRAT) for the benefit of himself and his children. On September 27, 2021 45,836 shares were distributed from the TL GRAT to the Family Trust in satisfaction of an annuity obligation. On September 22, 2022, 135,090 shares were distributed from the TL GRAT to the Family Trust in satisfaction of an annuity obligation. Upon termination of the trust on September 27, 2022, the remaining 383,764 shares were transferred to the children of the Reporting Person. The 180,926 shares previously distributed to the Family Trust will continue to be reported as indirectly owned by the Reporting Person.

SEC source: 0001250853-22-000096 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 799,855

F1 · balance_after: These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002 (the Family Trust). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-21-021872 · wf-form4_163607193862764.xml · derivative · entry 6

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,502

Underlying: Common Stock · 29,502 shares

Expires 2026-11-02

F5 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the option shall vest in three equal annual installments commencing on the first anniversary of November 2, 2021.

SEC source: 0001628280-21-021872 · wf-form4_163607193862764.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,827

SEC source: 0001250853-21-000044 · primary_doc.xml · derivative · entry 6

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 0

Underlying: Common Stock · 31,755 shares

Expires 2021-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001250853-21-000044 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 908,183

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-21-062587 · tm2115461-1_4seq1.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 908,183

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-21-062587 · tm2115461-1_4seq1.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 876,428

F1 · kind: Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied Physicians of California, A Profession Medical Corporation ("Allied") of which the Reporting Person is a director, officer and shareholder.

F1 · shares: Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied Physicians of California, A Profession Medical Corporation ("Allied") of which the Reporting Person is a director, officer and shareholder.

F1 · acquired: Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied Physicians of California, A Profession Medical Corporation ("Allied") of which the Reporting Person is a director, officer and shareholder.

F2 · balance_after: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001250853-20-000110 · primary_doc.xml · derivative · entry 6

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,502

Underlying: Common Stock · 29,502 shares

Expires 2025-12-10

F5 · derivative.exercise_date: The option vests in three equal annual installments commencing on November 11, 2020.

SEC source: 0001250853-20-000110 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,585

SEC source: 0001250853-20-000079 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 690,490

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.225 to $17.33, inclusive. The reporting person undertakes to provide to Apollo Medical Holdings, Inc., any security holder of Apollo Medical Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

F2 · balance_after: These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001250853-20-000072 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wife

Disclosed balance after: 564,691

F1 · kind: On September 10, 2020, the Reporting Person and his spouse entered into a transmutation agreement pursuant to which the Reporting Person and his spouse agreed that 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of his spouse and 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of the Reporting Person.

F3 · ownership.nature: These securities are beneficially owned by the Reporting Person's spouse as separate property pursuant to the transmutation agreement referred to in footnote one. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

SEC source: 0001250853-20-000072 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 685,490

F1 · kind: On September 10, 2020, the Reporting Person and his spouse entered into a transmutation agreement pursuant to which the Reporting Person and his spouse agreed that 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of his spouse and 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of the Reporting Person.

F2 · ownership.nature: These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001250853-20-000068 · primary_doc.xml · nonDerivative · entry 3

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,814,872

F1 · ownership.nature: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001250853-20-000068 · primary_doc.xml · derivative · entry 6

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 0

Underlying: Common Stock · 63,510 shares

Expires 2020-10-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001250853-20-000068 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,809,872

F1 · ownership.nature: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001250853-20-000068 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,840,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-20-100935 · tm2029851d1_4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 1,776,614

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.20 to $18.30. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-19-076941 · tm1928380d3_4.xml · derivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,046

Underlying: Common Stock · 28,046 shares

Expires 2024-12-30

F2 · derivative.exercise_price: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company.

F2 · kind: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company.

F2 · derivative.exercise_date: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company.

SEC source: 0001104659-19-076941 · tm1928380d3_4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,343

F1 · kind: Restricted shares of Common Stock of Apollo Medical Holdings, Inc. (the "Company") granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022).